Table 4.

Diagnostic performance of miRNAs in gliomas.

Analysis	Overall	Outliers excluded
No. of studies	24	20
Sen (95% CI)	0.84 (0.79–0.87)	0.83 (0.79–0.87)
Spe (95% CI)	0.84 (0.80–0.88)	0.83 (0.79–0.87)
PLR (95% CI)	5.3 (4.1–6.8)	5.0 (4.0–6.3)
NLR (95% CI)	0.19 (0.15–0.25)	0.20 (0.16–0.25)
DOR (95% CI)	27 (18–41)	25 (17–36)
AUC (95% CI)	0.91 (0.88–0.93)	0.90 (0.87–0.92)

Sen, sensitivity; Spe, specificity; PLR, positive likelihood ratio; NLR, negative likelihood ratio; DOR, diagnostic odds ratio; AUC, area under the curve; CI, confidence interval.